lactic acid has been researched along with organophosphonates in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (46.67) | 29.6817 |
| 2010's | 8 (53.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Birkus, G; Cihlar, T; Hitchcock, MJ | 1 |
| Blanco-Príeto, MJ; Ga de Jalón, E; Renedo, MJ; Santoyo, S; Ygartua, P | 1 |
| Czarnecka, B; Limanowska-Shaw, H; Nicholson, JW | 1 |
| Chandramouli, VC; Dang, Q; Erion, MD; Landau, BR; Potter, SC; van Poelje, PD | 1 |
| Bogner, J; Claas, GJ; Goebel, FD; Jülg, B | 1 |
| Melkaoui, K; Setzer, B; Venhoff, N; Walker, UA | 1 |
| Fujiwara, T; Hagisawa, Y; Kanda, S; Nakashima, R; Ogawa, J; Okuno, A; Takahashi, K; Tanaka, J; Yoshida, T | 1 |
| Fujiwara, T; Hagisawa, Y; Kanda, S; Ogawa, J; Okuno, A; Takahashi, K; Yoshida, T | 1 |
| Sturgis, TF; Youan, BB; Zhang, T | 1 |
| Baraldi, C; Belletti, D; Forni, F; Gamberini, MC; Ruozi, B; Tosi, G; Vandelli, MA | 1 |
| Buchalla, W; Buzalaf, MA; Comar, LP; Magalhães, AC; Moron, BM; Wiegand, A; Yu, H | 1 |
| Dulaurent, S; Gaulier, JM; Lachâtre, G; Moesch, C; Zouaoui, K | 1 |
| Ball, C; Chaowanachan, T; Krogstad, E; Woodrow, KA | 1 |
| Aggeletopoulou, I; Anastassiou, ED; Assimakopoulos, S; Gogos, C; Kalafateli, M; Labropoulou-Karatza, C; Mandellou, M; Taprantzi, D; Thomopoulos, K; Triantos, C; Tselekouni, P; Tsiaoussis, G; Vourli, G | 1 |
| Ayoub, MM; El-Nahas, HM; Elantouny, NG; Ghazy, FES | 1 |
1 trial(s) available for lactic acid and organophosphonates
| Article | Year |
|---|---|
Metabolic and anthropometric changes one year after switching from didanosine/stavudine to tenofovir in HIV-infected patients.
Topics: Adenine; Adult; Aged; Anti-HIV Agents; Body Weight; CD4 Lymphocyte Count; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Creatinine; Didanosine; Female; Glomerular Filtration Rate; Glycated Hemoglobin; Hemoglobins; HIV Infections; Humans; Lactic Acid; Male; Middle Aged; Organophosphonates; Phosphates; Skinfold Thickness; Stavudine; Tenofovir; Treatment Outcome; Triglycerides; Uric Acid; Viral Load | 2007 |
14 other study(ies) available for lactic acid and organophosphonates
| Article | Year |
|---|---|
Assessment of mitochondrial toxicity in human cells treated with tenofovir: comparison with other nucleoside reverse transcriptase inhibitors.
Topics: Adenine; Cells, Cultured; DNA, Mitochondrial; Electron Transport Complex IV; Humans; Immunoblotting; Kidney Tubules, Proximal; Lactic Acid; Liver; Mitochondria; Muscle, Skeletal; Organophosphonates; Organophosphorus Compounds; Reverse Transcriptase Inhibitors; Tenofovir; Tumor Cells, Cultured | 2002 |
Optimization of topical cidofovir penetration using microparticles.
Topics: Administration, Topical; Animals; Antiviral Agents; Cidofovir; Cytosine; Delayed-Action Preparations; Drug Compounding; Ear, External; In Vitro Techniques; Lactic Acid; Microspheres; Organophosphonates; Organophosphorus Compounds; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Skin Absorption; Solvents; Swine | 2002 |
The interaction of glass-ionomer cements containing vinylphosphonic acid with water and aqueous lactic acid.
Topics: Glass Ionomer Cements; Lactic Acid; Materials Testing; Organophosphonates; Vinyl Compounds | 2003 |
Inhibition of fructose 1,6-bisphosphatase reduces excessive endogenous glucose production and attenuates hyperglycemia in Zucker diabetic fatty rats.
Topics: Alanine; Animals; Blood Glucose; Body Weight; Cholesterol; Diabetes Mellitus, Type 2; Eating; Female; Fructose-Bisphosphatase; Gluconeogenesis; Glucose; Hyperglycemia; Insulin; Ketone Bodies; Lactic Acid; Male; Molecular Structure; Organophosphonates; Organophosphorus Compounds; Pancreas; Rats; Rats, Zucker; Triglycerides | 2006 |
Mitochondrial toxicity of tenofovir, emtricitabine and abacavir alone and in combination with additional nucleoside reverse transcriptase inhibitors.
Topics: Adenine; Anti-HIV Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Deoxycytidine; Dideoxynucleosides; DNA, Mitochondrial; Emtricitabine; Humans; Lactic Acid; Lipid Metabolism; Mitochondria; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir | 2007 |
Metformin primarily decreases plasma glucose not by gluconeogenesis suppression but by activating glucose utilization in a non-obese type 2 diabetes Goto-Kakizaki rats.
Topics: Alanine; Animals; Blood Glucose; Cells, Cultured; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Fructose-Bisphosphatase; Gluconeogenesis; Glucose; Hepatocytes; Hypoglycemic Agents; Inhibitory Concentration 50; Insulin; Lactic Acid; Male; Metformin; Organophosphonates; Organophosphorus Compounds; Radioisotope Dilution Technique; Rats; Rats, Mutant Strains; Rats, Wistar | 2009 |
Contributions of hepatic gluconeogenesis suppression and compensative glycogenolysis on the glucose-lowering effect of CS-917, a fructose 1,6-bisphosphatase inhibitor, in non-obese type 2 diabetes Goto-Kakizaki rats.
Topics: Alanine; Amides; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Drug Evaluation, Preclinical; Fasting; Gluconeogenesis; Glucose; Glycogenolysis; Hypoglycemic Agents; Indoles; Lactic Acid; Male; Organophosphonates; Organophosphorus Compounds; Peptide Hydrolases; Rats | 2011 |
pH-responsive nanoparticles releasing tenofovir intended for the prevention of HIV transmission.
Topics: Adenine; Administration, Intravaginal; Anti-HIV Agents; Cell Line; Cell Survival; Drug Carriers; Drug Compounding; Epithelial Cells; Female; HIV Infections; Humans; Hydrogen-Ion Concentration; Lactic Acid; Lactobacillus; Microscopy, Confocal; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Nanoparticles; Organophosphonates; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymethacrylic Acids; Solubility; Surface Properties; Tenofovir; Vagina | 2011 |
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles.
Topics: Adenine; Anti-HIV Agents; Chitosan; Drug Carriers; Lactic Acid; Nanoparticles; Organophosphonates; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Tenofovir | 2012 |
Different protocols to produce artificial dentine carious lesions in vitro and in situ: hardness and mineral content correlation.
Topics: Acetic Acid; Anatomy, Cross-Sectional; Animals; Biofilms; Buffers; Calcium; Carboxymethylcellulose Sodium; Cariogenic Agents; Cariostatic Agents; Cattle; Dental Plaque; Dentin; Fluorides; Hardness; Humans; Hydrogen-Ion Concentration; Lactic Acid; Microradiography; Minerals; Organophosphonates; Phosphates; Research Design; Sucrose; Tooth Demineralization | 2013 |
Determination of glyphosate and AMPA in blood and urine from humans: about 13 cases of acute intoxication.
Topics: Accidents; Acidosis; Adult; Aged; Arrhythmias, Cardiac; Chemical and Drug Induced Liver Injury; Chromatography, High Pressure Liquid; Consciousness Disorders; Deglutition Disorders; Disseminated Intravascular Coagulation; Female; Forensic Toxicology; Glycine; Glyphosate; Heart Arrest; Hemodynamics; Herbicides; Humans; Hyperkalemia; Isoxazoles; Lactic Acid; Male; Mass Spectrometry; Middle Aged; Multiple Organ Failure; Nausea; Organophosphonates; Oropharynx; Pharyngeal Diseases; Pharyngitis; Renal Insufficiency; Respiratory Distress Syndrome; Shock; Suicide; Tetrazoles; Ulcer; Vomiting | 2013 |
Drug synergy of tenofovir and nanoparticle-based antiretrovirals for HIV prophylaxis.
Topics: Adenine; Alkynes; Animals; Anti-HIV Agents; Benzoxazines; Cell Line; Cervix Uteri; Chemistry, Pharmaceutical; Cyclopropanes; Delayed-Action Preparations; Drug Carriers; Drug Synergism; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Inhibitory Concentration 50; Lactic Acid; Macaca; Models, Biological; Nanoparticles; Organophosphonates; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Saquinavir; Spectroscopy, Fourier Transform Infrared; Tenofovir; Tissue Culture Techniques | 2013 |
Lactate serum concentrations during treatment with nucleos(t)ide analogues in hepatitis B with or without cirrhosis.
Topics: Acidosis, Lactic; Adenine; Adult; Aged; Aged, 80 and over; Antiviral Agents; Biomarkers; Drug Therapy, Combination; Female; Guanine; Hepatitis B, Chronic; Humans; Lactic Acid; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Organophosphonates; Prospective Studies; Risk Factors; Sex Factors; Tenofovir; Time Factors; Treatment Outcome; Up-Regulation; Young Adult | 2017 |
Injectable PLGA Adefovir microspheres; the way for long term therapy of chronic hepatitis-B.
Topics: Adenine; Animals; Antiviral Agents; Drug Delivery Systems; Drug Liberation; Hepatitis B, Chronic; Lactic Acid; Male; Microspheres; Organophosphonates; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats | 2018 |